Subscribe to our monthly newsletter to receive exclusive news updates and medical AI insights.
News
Featured News
Enhancing Cardiovascular Care: The Story of DEEPVESSEL FFR by Keya Medical
Keya Medical’s DEEPVESSEL FFR offers a non-invasive, accurate, and efficient solution for assessing coronary artery function. The product’s journey from inception to global clearances reflects a commitment to advancing medical technology and improving patient outcomes...
Keya Medical Receives Strategic Investment
Keya Medical announced today that it has received a strategic investment from Kunlun Wanwei Group, IDG Capital, Shanghai Guofang Parent Fund, and Yahui Capital.
DEEPVESSEL FFR is Approved for Clinical Use in China
On January 15, 2020, the National Medical Products Administration in China issued the registration certificate approving DeepVessel FFR for clinical use.
Regulating Artificial Intelligence in Radiological Imaging
Explore the risks and benefits of AI applications in radiology, according to industry stakeholders and the U.S. FDA.
Keya Medical Attends 10th Summit on Scientific and Technological Innovation in Major Disease Control
The 10th Summit on Scientific and Technological Innovation in Major Disease Control sponsored by the Beijing Municipal Science and Technology Commission, took place on Dec. 21, 2019 at the National Convention Center.
Keya Medical Selected in Top 100 Medical Companies of the Future
The Future Medical 100 Annual Conference was held Dec. 20, 2019 in Beijing Jiuhua Villa. Keya Medical was among the companies listed on the Top 100 List, and DEEPVESSEL FFR made the list of the Top 5 FFR Products in China.
Keya Medical and Shunde Hospital of Southern Medical University Bring Non-invasive CT-FFR to Patients
Keya Medical’s non-invasive CT-FFR product, DEEPVESSEL FFR, was officially implemented in Shunde Hospital of Southern Medical University.
CuraCloud Works with NVIDIA to Bring Advanced AI Tools to Healthcare
As a member of NVIDIA’s Inception Program, CuraCloud has had early access to NVIDIA’s AI development tools, including NVIDIA Clara, the NVIDIA EGX Intelligent Edge Computing Platform, and NVIDIA AGX for embedded systems.
DEEPVESSEL FFR Implemented in Civil Aviation General Hospital
Keya Medical’s non-invasive coronary evaluation software, DEEPVESSEL FFR, was successfully installed at China Civil Aviation General Hospital on Dec. 2, 2019.
Understanding the Turnaround Time Effects of an AI-based Prioritization System for Intracranial Hemorrhage
We built a Monte Carlo simulation to understand the turnaround time effects of an AI-based prioritization system for intracranial hemorrhage.
The Big Data Boom in Chest Radiography
With the recent advancements in computer vision and AI, we look at the two largest public CXR datasets and identify future trends.
DEEPVESSEL FFR Receives CE Mark
Keya Medical announced on September 21, 2018 that DEEPVESSEL FFR received ISO 13485:2016 certification for Medical Device and Quality Managements Systems as well as its CE Mark Certification after a series of on-site audits and evaluations by its notified body, DEKRA.
CuraCloud and Clario Announce Co-Development Agreement
CuraCloud today announced it has partnered with Clario Medical to create new deep deep learning models to accelerate the identification and potential critical results to the top of the radiologist’s exam reading queue.
